BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Leukocyte
,
Early pregnancy factor
,
Bleomycin
,
rs6983267
,
BRCA1
,
cell-cell adhesion
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
HELLP syndrome
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
HADHA
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
mitochondrial fatty acid beta-oxidation multienzyme complex
Fatty acid oxidation complex, alpha subunit, mitochondrial
3-hydroxyacyl-CoA dehydrogenase, C-terminal
3-hydroxyacyl-CoA dehydrogenase, NAD binding
3-hydroxyacyl-CoA dehydrogenase, conserved site
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Placentas of pregnancies complicated by pre-eclampsia and HELLP syndrome
OMIM - Vascular disease
OMIM - HELLP syndrome
Explore Curated Studies Results
Literature
Most Relevant Literature
Placental expression of vimentin, desmin and ultrastructural changes in the villi in patients with H…
Eculizumab for the treatment of preeclampsia/HELLP syndrome.
Circulating levels of thrombospondin-1 are decreased in HELLP syndrome.
Seeking the mechanism(s) of action for corticosteroids in HELLP syndrome: SMASH study.
HELLP syndrome and its relationship with antiphospholipid syndrome and antiphospholipid antibodies.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Use of Eculizumab in HELLP Syndrome
Promising Bimarker Prediction of Outcome of HELLP Syndrome.
Effectivity of Postpartum Dexamethasone for Women With Class I HELLP Syndrome
Immature Platelet Fraction as a Promising Biomarker in Prediction Outcome of HELLP Syndrome
Dexamethasone Efficacy in HELLP I Syndrome
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ